BBR Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-557
| Closed | -$324K | – | 261 |
|
|
2024
Q1 | $324K | Buy |
+557
| New | +$324K | 0.03% | 183 |
|
|
2023
Q4 | – | Sell |
-623
| Closed | -$315K | – | 224 |
|
|
2023
Q3 | $315K | Buy |
+623
| New | +$315K | 0.04% | 140 |
|
|
2022
Q3 | – | Sell |
-995
| Closed | -$541K | – | 228 |
|
|
2022
Q2 | $541K | Hold |
995
| – | – | 0.06% | 122 |
|
|
2022
Q1 | $588K | Sell |
995
-31
| -3% | -$18.3K | 0.06% | 123 |
|
|
2021
Q4 | $685K | Sell |
1,026
-9
| -0.9% | -$6.01K | 0.08% | 100 |
|
|
2021
Q3 | $591K | Buy |
1,035
+11
| +1% | +$6.28K | 0.05% | 114 |
|
|
2021
Q2 | $517K | Sell |
1,024
-25
| -2% | -$12.6K | 0.04% | 113 |
|
|
2021
Q1 | $479K | Sell |
1,049
-647
| -38% | -$295K | 0.04% | 125 |
|
|
2020
Q4 | $790K | Buy |
1,696
+54
| +3% | +$25.2K | 0.07% | 93 |
|
|
2020
Q3 | $725K | Buy |
1,642
+762
| +87% | +$336K | 0.06% | 95 |
|
|
2020
Q2 | $319K | Buy |
+880
| New | +$319K | 0.04% | 127 |
|
|
2020
Q1 | – | Sell |
-707
| Closed | -$230K | – | 205 |
|
|
2019
Q4 | $230K | Buy |
+707
| New | +$230K | 0.03% | 174 |
|